NeoPharm CO. LTD (092730) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.031x

Based on the latest financial reports, NeoPharm CO. LTD (092730) has a cash flow conversion efficiency ratio of 0.031x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.88 Billion ≈ $3.98 Million USD) by net assets (₩188.40 Billion ≈ $127.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NeoPharm CO. LTD balance sheet independence to measure how much of total assets are equity-financed.

NeoPharm CO. LTD - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how NeoPharm CO. LTD's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 092730 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

NeoPharm CO. LTD Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NeoPharm CO. LTD ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Synchronoss Technologies Inc NASDAQ:SNCR	0.711x
Havila Kystruten AS OL:HKY	-0.034x
Woongjin Co Ltd KO:016880	0.275x
Active Biotech AB ST:ACTI	-1.600x
Social Commerce Partners Corporation Class A Ordinary Shares NASDAQ:SCPQ	N/A
Vivani Medical Inc. NASDAQ:VANI	-0.427x
Xtract One Technologies Inc. TO:XTRA	-0.220x
SA Catana Group PA:CATG	0.120x

Annual Cash Flow Conversion Efficiency for NeoPharm CO. LTD (2012–2024)

The table below shows the annual cash flow conversion efficiency of NeoPharm CO. LTD from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see market value of NeoPharm CO. LTD.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩176.88 Billion ≈ $119.87 Million	₩18.63 Billion ≈ $12.63 Million	0.105x	-27.54%
2023-12-31	₩160.03 Billion ≈ $108.45 Million	₩23.26 Billion ≈ $15.76 Million	0.145x	+13.83%
2022-12-31	₩142.21 Billion ≈ $96.37 Million	₩18.16 Billion ≈ $12.31 Million	0.128x	-23.25%
2021-12-31	₩130.30 Billion ≈ $88.31 Million	₩21.68 Billion ≈ $14.69 Million	0.166x	+14.72%
2020-12-31	₩117.72 Billion ≈ $79.78 Million	₩17.07 Billion ≈ $11.57 Million	0.145x	-20.26%
2019-12-31	₩105.69 Billion ≈ $71.63 Million	₩19.22 Billion ≈ $13.03 Million	0.182x	-33.35%
2018-12-31	₩59.29 Billion ≈ $40.18 Million	₩16.18 Billion ≈ $10.96 Million	0.273x	+21.97%
2017-12-31	₩47.58 Billion ≈ $32.25 Million	₩10.65 Billion ≈ $7.21 Million	0.224x	-5.75%
2016-12-31	₩38.57 Billion ≈ $26.14 Million	₩9.16 Billion ≈ $6.21 Million	0.237x	+27.07%
2015-12-31	₩32.62 Billion ≈ $22.11 Million	₩6.09 Billion ≈ $4.13 Million	0.187x	+890.58%
2012-12-31	₩29.92 Billion ≈ $20.28 Million	₩564.34 Million ≈ $382.45K	0.019x	--

About NeoPharm CO. LTD

KQ:092730 Korea Personal & Household Products & Services

Market Cap

$103.51 Million

₩152.74 Billion KRW

Market Cap Rank

#19006 Global

#887 in Korea

Share Price

₩19120.00

Change (1 day)

+3.07%

52-Week Range

₩15760.00 - ₩22150.00

All Time High

₩27383.15